Literature DB >> 28577945

Systematic identification of cancer-related long noncoding RNAs and aberrant alternative splicing of quintuple-negative lung adenocarcinoma through RNA-Seq.

Lu Zhang1, Shiyong Li2, Yoon-La Choi3, Jinseon Lee3, Zhuolin Gong2, Xiaoqiao Liu4, Yunfei Pei4, Awei Jiang2, Mingzhi Ye2, Mao Mao5, Xuegong Zhang6, Jhingook Kim7, Ronghua Chen8.   

Abstract

OBJECTIVES: Lung adenocarcinoma (LUAD) is a common subtype of non-small cell lung cancer prevalent in Asia. There is a dearth of understanding regarding the transcriptome landscape of LUAD without primary known driver mutations. In this study, LUAD samples without well-known driver mutations occurring in EGFR, KRAS, ALK, ROS1 or RET (quintuple-negative) were used for transcriptome study with a focus on long noncoding RNAs (lncRNAs), alternative splicing and gene fusions.
MATERIALS AND METHODS: 24 pairs of LUAD and adjacent normal samples and 13 tumor-only samples derived from 37 quintuple-negative patients were used. Differentially expressed lncRNA transcripts were detected by paired t-test and were validated by qPCR. Functions of lncRNAs were predicted by co-expressed mRNAs. Aberrant splicing events in LUAD were identified using MISO. In addition, gene fusions were screened by SOAPfuse. RESULTS AND
CONCLUSION: In total, 90 and 153 up- or down-regulated lncRNA transcripts were detected in LUAD samples in comparison with the adjacent normal samples. The most significantly differentially expressed lncRNA transcript was ENST00000598996.1 (FENDRR) down-regulated in LUAD. By lncRNA-mRNA co-expression analysis, functions of 14 lncRNAs were predicted. The predicted functions included vasculature development, immune response, cell cycle and respiratory gaseous exchange. Furthermore, six co-expressed pairs of lncRNAs and their nearby protein coding genes were identified as associated with lung development. This study also identified two highly recurrent (22 in 24) differential exon skipping events occurring in MYH14 and ESYT2 with exon including isoforms of both genes up-regulated in isoform percentage in LUAD samples. On the other hand, two out of 24 LUAD samples possessed the driver mutation exon 14 skipping of MET. The transcriptional alterations of LUAD samples without well-known driver mutations identified in the study can be used as references for future research. The translational values of these transcriptional changes are also worthy of further investigation.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alternative splicing; Co-expression; LncRNA; Lung adenocarcinoma; Quintuple-negative

Mesh:

Substances:

Year:  2017        PMID: 28577945     DOI: 10.1016/j.lungcan.2017.04.009

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  13 in total

1.  RNA-sequencing study of peripheral blood mononuclear cells in sporadic Ménière's disease patients: possible contribution of immunologic dysfunction to the development of this disorder.

Authors:  Y Sun; D Zhang; G Sun; Y Lv; Y Li; X Li; Y Song; J Li; Z Fan; H Wang
Journal:  Clin Exp Immunol       Date:  2017-12-11       Impact factor: 4.330

2.  LncRNA TBX5-AS1 Regulates the Tumor Progression Through the PI3K/AKT Pathway in Non-Small Cell Lung Cancer.

Authors:  Qing-Hai Qu; Shui-Zheng Jiang; Xin-Ying Li
Journal:  Onco Targets Ther       Date:  2020-08-12       Impact factor: 4.147

3.  Integrated analysis of long non-coding RNAs in human gastric cancer: An in silico study.

Authors:  Weiwei Han; Zhenyu Zhang; Bangshun He; Yijun Xu; Jun Zhang; Weijun Cao
Journal:  PLoS One       Date:  2017-08-25       Impact factor: 3.240

Review 4.  The crucial role of multiomic approach in cancer research and clinically relevant outcomes.

Authors:  Miaolong Lu; Xianquan Zhan
Journal:  EPMA J       Date:  2018-02-21       Impact factor: 6.543

5.  [Bioinformatics Analysis of DNA Methylation in the Promoters of LincRNA 
in Lung Adenocarcinoma].

Authors:  Wen Zhang; Shaojun Li; Nannan Guo; Yingnan Zhao
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2018-06-20

6.  Nonmuscle myosin IIA and IIB differentially modulate migration and alter gene expression in primary mouse tumorigenic cells.

Authors:  Debdatta Halder; Shekhar Saha; Raman K Singh; Indranil Ghosh; Ditipriya Mallick; Sumit K Dey; Arijit Ghosh; Benu Brata Das; Somiranjan Ghosh; Siddhartha S Jana
Journal:  Mol Biol Cell       Date:  2019-04-17       Impact factor: 4.138

Review 7.  Exosomal Long Non-Coding RNAs in Lung Diseases.

Authors:  Christophe Poulet; Makon-Sébastien Njock; Catherine Moermans; Edouard Louis; Renaud Louis; Michel Malaise; Julien Guiot
Journal:  Int J Mol Sci       Date:  2020-05-19       Impact factor: 5.923

8.  Construction of a metastasis-associated ceRNA network reveals a prognostic signature in lung cancer.

Authors:  Qing Cao; Zewen Dong; Shuzhen Liu; Guoyan An; Bianbian Yan; Lei Lei
Journal:  Cancer Cell Int       Date:  2020-06-03       Impact factor: 5.722

9.  Profiling expression of coding genes, long noncoding RNA, and circular RNA in lung adenocarcinoma by ribosomal RNA-depleted RNA sequencing.

Authors:  Xiangxiang Ding; Shuai Zhang; Xiao Li; Changjiang Feng; Qi Huang; Shaodong Wang; Siwei Wang; Wenjia Xia; Fan Yang; Rong Yin; Lin Xu; Mantang Qiu; Ming Li; Jun Wang
Journal:  FEBS Open Bio       Date:  2018-02-21       Impact factor: 2.693

10.  Identification of a 4-lncRNA signature predicting prognosis of patients with non-small cell lung cancer: a multicenter study in China.

Authors:  Rui-Qi Wang; Xiao-Ran Long; Chun-Lei Ge; Mei-Yin Zhang; Long Huang; Ning-Ning Zhou; Yi Hu; Rui-Lei Li; Zhen Li; Dong-Ni Chen; Lan-Jun Zhang; Zhe-Sheng Wen; Shi-Juan Mai; Hui-Yun Wang
Journal:  J Transl Med       Date:  2020-08-20       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.